Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


PharmAthene Receives Tech Company of the Year Award from Anne Arundel Tech Council

    ANNAPOLIS, Md., Nov. 6 /PRNewswire/ -- PharmAthene, Inc., a leading
biodefense company specializing in the development and commercialization of
medical countermeasures against chemical and biological terrorism,
announced today that it has received the 'Tech Company of the Year' award
from the Anne Arundel Tech Council. The Tech Company of the Year award
recognizes companies that have exhibited entrepreneurial strength, vision
and rapid growth. The award was presented to PharmAthene during the second
annual 'TechAwards' celebration in Annapolis, Maryland.
    "Anne Arundel County is becoming one of the leading technology centers
in the mid-Atlantic area, and we are pleased and honored to be recognized
as an innovative force within this unique region," commented David P.
Wright, President and Chief Executive Officer. "We remain grateful to the
many organizations, including the Anne Arundel Economic Development
Corporation and the Chesapeake Innovation Center, and countless individuals
who have tirelessly campaigned to foster a thriving high technology
industry within Anne Arundel County. We look forward to continuing to
participate in the success of this dynamic region."
    About PharmAthene, Inc.
    PharmAthene, a privately-held biotechnology company, is dedicated to
the rapid development of important and novel medical countermeasures to
address biological pathogens and chemicals that may be used as weapons of
bioterror. PharmAthene's lead programs include Valortim(TM), intended for
the prevention and treatment of anthrax, which is being co-developed with
Medarex, Inc., and Protexia(R), intended to prevent and treat nerve agent
toxicity. PharmAthene is located in the Chesapeake Innovation Center in
Annapolis, MD, America's first business accelerator for the homeland and
national security sectors. PharmAthene has been successful in obtaining
U.S. Government and Venture Capital funding to finance the development of
its portfolio products. For more information on PharmAthene, please visit
http://www.PharmAthene.com.


SOURCE PharmAthene, Inc.




Back to Topback to top

Related links:
  • http://www.pharmathene.com/
    CONTACT:
    Stacey Jurchison, Director, Corporate
    Communications of PharmAthene, Inc., +1-410-571-8925, or Cell:
    +1-410-474-8200, or JurchisonS@PharmAthene.com